DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Bergh J, Jönsson PE, Lidbrink EK. et al.
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptorpositive postmenopausal breast cancer.
J Clin Oncol 2012;
30: 1919-1925
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.